| Segment Information |
Note 10 — Segment Information
The Company conducts business as a single operating segment which is based upon the Company’s organizational and management structure, as well as information used by the Chief Operating Decision Maker (“CODM”) to allocate resources and other factors. The accounting policies of the segment are the same as those described in Note 2. The key measure of segment profitability that the CODM uses to allocate resources and assess performance is consolidated net income (loss), as reported on the unaudited condensed consolidated statements of operations. The following table presents the significant revenue and expense categories of the Company’s single operating segment.
|
|
|
For the three months ended
September 30,
|
| |
|
2025
|
|
2024
|
| |
|
(Unaudited)
|
|
(Unaudited)
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Clinical trial related service fee
|
|
$
|
4,125,000 |
|
$
|
2,801,000 |
|
Consulting fee
|
|
|
17,228 |
|
|
25,000 |
|
Stock-based compensation
|
|
|
152,421 |
|
|
—
|
|
Salary expense
|
|
|
132,054 |
|
|
133,811 |
|
Professional fee
|
|
|
184,791 |
|
|
293,934 |
|
Insurance expense
|
|
|
86,690 |
|
|
88,456 |
|
Other general and administrative fee
|
|
|
102,965 |
|
|
34,536 |
|
Loss before income tax
|
|
|
4,801,149 |
|
|
3,376,737 |
| |
|
|
|
|
|
|
|
Income tax expense
|
|
|
—
|
|
|
—
|
|
Net loss
|
|
$
|
4,801,149 |
|
$
|
3,376,737 |
|
|
|
For the nine months ended
September 30,
|
| |
|
2025
|
|
2024
|
| |
|
(Unaudited)
|
|
(Unaudited)
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Clinical trial related service fee
|
|
$
|
10,125,000 |
|
$
|
6,301,000 |
|
Consulting fee
|
|
|
67,228 |
|
|
75,000 |
|
Stock-based compensation
|
|
|
470,614 |
|
|
—
|
|
Salary expense
|
|
|
392,861 |
|
|
385,360 |
|
Professional fee
|
|
|
945,318 |
|
|
645,238 |
|
Insurance expense
|
|
|
251,383 |
|
|
263,443 |
|
Other general and administrative fee
|
|
|
197,071 |
|
|
125,673 |
|
Loss before income tax
|
|
|
12,449,475 |
|
|
7,795,714 |
| |
|
|
|
|
|
|
|
Income tax expense
|
|
|
863 |
|
|
1,625 |
|
Net loss
|
|
$
|
12,450,338 |
|
$
|
7,797,339 |
|